Huaxin Securities: Maintains a "buy" rating on Universal Healthcare (02666.HK) Health technology is the core driving force of the growth of the medical business.

According to the Wise Financial APP, Huatai Securities released a research report stating that it maintains a "buy" rating for Universal Medical (02666.HK), with estimated operating income of 14.795/15.347/16.182 billion yuan for the years 2025-2027, representing a year-on-year increase of +8%/4%/5%; achieving net profit attributable to the parent company of 20.95/22.30/23.56 billion yuan, with a year-on-year increase of +3%/6%/6%. The company released its 2025 interim report, with operating income of 7.581 billion yuan for the first half of 2025, a year-on-year increase of 15.9%; achieving a net profit attributable to the parent company's shareholders of 1.228 billion yuan, a year-on-year increase of 8%.